TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1671113

Group type: EXPERIMENTAL
Intervention: felodipine 5 mg with grapefruit juice
Number of subjects: 6

Group type: COMPARATOR
Intervention: felodipine 5 mg with water
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg with grapefruit juice
Number of subjects: 6

Group type: COMPARATOR
Intervention: nifedipine 10 mg with water
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: felodipine 5 mg with orange juice
Number of subjects: 6
Study: 6875007

Group type: EXPERIMENTAL
Intervention: Peer pressure condition (Group one)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Authority pressure condition (Group two)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No-pressure control condition (Group three)
Number of subjects: 44
Study: 31691521

Group type: EXPERIMENTAL
Intervention: Fast-Track Treatment Initiation Counselling (FTIC)
Number of subjects: 730

Group type: COMPARATOR
Intervention: Standard of care (Control)
Number of subjects: 730
Study: 30122196

Group type: EXPERIMENTAL
Intervention: High Protein (HP) diet (29% protein, 34% carbohydrate, 31% fat)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Higher-Carbohydrate (HC) diet (21% protein, 48% carbohydrate, 24% fat)
Number of subjects: 61
Study: 26982115

Group type: EXPERIMENTAL
Intervention: Laparoscopic pyloromyotomy (LP)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Open pyloromyotomy (OP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Controls (no abdominal procedures)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Laparoscopic pyloromyotomy (LP) and Controls
Number of subjects: 19
Study: 24618208

Group type: EXPERIMENTAL
Intervention: Highest dose of rosuvastatin (40 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Add-on-statin extended release nicotinic acid (ER-NA)/laropiprant (1000/20 mg/day for the first 4 weeks followed by 2000/40 mg/day for the next 8 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Add-on-statin micronized fenofibrate (200 mg/day)
Number of subjects: 100
Study: 23104210

Group type: EXPERIMENTAL
Intervention: Relapse (reported being a current smoker)
Number of subjects: 31894

Group type: EXPERIMENTAL
Intervention: Continued smoking
Number of subjects: 31894

Group type: EXPERIMENTAL
Intervention: Predictive model for relapse
Number of subjects: 31894

Group type: EXPERIMENTAL
Intervention: Predictive model for continued smoking
Number of subjects: 31894
Study: 20702607

Group type: EXPERIMENTAL
Intervention: 1-year lifestyle modification regimen including a 12-week very-low-calorie diet
Number of subjects: 81

Group type: COMPARATOR
Intervention: Routine lifestyle counseling (Control)
Number of subjects: 81
Study: 17667477

Group type: EXPERIMENTAL
Intervention: Youths with schizophrenia (SZ)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Youths with schizoaffective disorder
Number of subjects: 119

Group type: COMPARATOR
Intervention: Comparison to published reports of adults with SZ
Number of subjects: 119
Study: 16109147

Group type: EXPERIMENTAL
Intervention: Librarian present in PBL groups
Number of subjects: 164

Group type: COMPARATOR
Intervention: No librarian present in PBL groups
Number of subjects: 164
Study: 15218894

Group type: EXPERIMENTAL
Intervention: Chewing gums (8 different types)
Number of subjects: 83
Study: 10331155

Group type: EXPERIMENTAL
Intervention: Malnourished infants (MI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy control infants (CI)
Number of subjects: 10
Study: 8707125

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (EST-R)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (EST-NR)
Number of subjects: 50
Study: 1950641

Group type: EXPERIMENTAL
Intervention: Intranasally administered (DesGly9‐Arg8) vasopressin (DGAVP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 7028050

Group type: EXPERIMENTAL
Intervention: Ciclopiroxolamine cream (1% concentration) applied for 21 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle (placebo cream) applied for 21 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ciclopiroxolamine cream (1% concentration)
Number of subjects: 60
Study: 29722071

Group type: EXPERIMENTAL
Intervention: Daily text messages with patient education material and treatment reminders
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 42
Study: 27305954

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA-rich fish oil (3 g/d) for 90 d
Number of subjects: 72

Group type: COMPARATOR
Intervention: corn oil (control) for 90 d
Number of subjects: 72
Study: 24682504

Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 21239069

Group type: EXPERIMENTAL
Intervention: losartan (weight-adjusted treatment)
Number of subjects: 174

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 174
Study: 20148911

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg/day)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study: 18675344

Group type: EXPERIMENTAL
Intervention: Griseofulvin lyophilized dry emulsion (LDE) tablet (125 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Griseofulvin lyophilized dry emulsion (LDE) tablet (125 mg) with water
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Griseofulvin lyophilized dry emulsion (LDE) tablet (125 mg) without water
Number of subjects: 9

Group type: COMPARATOR
Intervention: Immediate release (IR) tablet
Number of subjects: 9
Study: 15982992

Group type: EXPERIMENTAL
Intervention: alpha-lactalbumin protein administration
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 12436353

Group type: EXPERIMENTAL
Intervention: Enteral nutrition with fibre and lactobacillus plantarum 299
Number of subjects: 172

Group type: COMPARATOR
Intervention: Conventional parenteral or enteral nutrition
Number of subjects: 172

Group type: COMPARATOR
Intervention: Enteral nutrition with fibre and heat inactivated lactobacilli (placebo)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Enteral nutrition with fibre and lactobacillus plantarum 299 (in liver transplant recipients)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Conventional parenteral or enteral nutrition (in liver transplant recipients)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Enteral nutrition with fibre and heat inactivated lactobacilli (placebo) (in liver transplant recipients)
Number of subjects: 172
Study: 10513715

Group type: EXPERIMENTAL
Intervention: Contact isolation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not in isolation
Number of subjects: 0
Study: 8881860

Group type: EXPERIMENTAL
Intervention: Dofetilide (8 micrograms.kg‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1669137

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of streptokinase (250,000 IU initial dose, 100,000 IU/h maintenance)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intermittent administration of streptokinase (500,000 IU initial dose, 250,000 IU every 12 h)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of streptokinase
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intermittent administration of streptokinase
Number of subjects: 55
Study: 6120902

Group type: EXPERIMENTAL
Intervention: 0.1 g atenolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.08 g propranolol
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study: 30832625

Group type: EXPERIMENTAL
Intervention: Occasional snorers
Number of subjects: 3794

Group type: EXPERIMENTAL
Intervention: Habitual snorers
Number of subjects: 3794

Group type: EXPERIMENTAL
Intervention: BMI ≥ 24
Number of subjects: 3794

Group type: EXPERIMENTAL
Intervention: Additive interaction between snoring and BMI
Number of subjects: 3794
Study: 27888045

Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg single dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24805971

Group type: EXPERIMENTAL
Intervention: Being a spouse
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Increasing scores on the Research Attitudes Questionnaire
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Research attitudes
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Being a spouse vs adult child
Number of subjects: 103
Study: 23292159

Group type: EXPERIMENTAL
Intervention: 4 mg nebulized inhalative epinephrine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 8 mg nebulized inhalative epinephrine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.3 mg intramuscular epinephrine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhalative administrations of epinephrine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 8 mg inhalative epinephrine
Number of subjects: 8
Study: 20381082

Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 50
Study: 19040458

Group type: EXPERIMENTAL
Intervention: Standard care + blowing soap bubbles
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Standard care + heated pillow
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Standard care + intervention (blowing soap bubbles or heated pillow)
Number of subjects: 28
Study: 16426956

Group type: EXPERIMENTAL
Intervention: Surgery in both eyes (intervention group)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Surgery in one eye only (control group)
Number of subjects: 296
Study: 15155959

Group type: EXPERIMENTAL
Intervention: High-dose argatroban (100 microg/kg bolus, 3 microg/kg per minute)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Low-dose argatroban (100 microg/kg bolus, 1 microg/kg per minute)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: All groups (including asymptomatic ICH)
Number of subjects: 171
Study: 11730824

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg per day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9164990

Group type: EXPERIMENTAL
Intervention: Diet rich in fat (50%) and poor in dietary fiber
Number of subjects: 7

Group type: COMPARATOR
Intervention: Vegetarian diet poor in fat (20%) and rich in dietary fiber
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Diet rich in fat and poor in dietary fiber
Number of subjects: 7

Group type: COMPARATOR
Intervention: Vegetarian diet poor in fat and rich in dietary fiber
Number of subjects: 7
Study: 8122501

Group type: EXPERIMENTAL
Intervention: Low cost multicomponent intervention program including information about the dangers of smoking in pregnancy and a self-help manual for a 10 day program
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group receiving a control ultrasound around the 32nd week of pregnancy with two encouraging reminders mailed before and after
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Low cost multicomponent intervention program
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 2504855

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 18
Study: 1059540

Group type: EXPERIMENTAL
Intervention: 9% stannous-fluoride treatment on right incisors before extraction
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unfluoridated left incisive teeth
Number of subjects: 10
Study: 31130270

Group type: EXPERIMENTAL
Intervention: Buteyko breathing technique in conjunction with medical management (nasal steroid)
Number of subjects: 51
Study: 26135277

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention in an emergency-setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established indicated prevention program
Number of subjects: 0
Study: 23203942

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural model of eating disorders
Number of subjects: 1451
Study: 21245669

Group type: EXPERIMENTAL
Intervention: Mental Practice (MP) - 30 minutes of MP before each laparoscopic cholecystectomy (LC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control - viewed an online lecture
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mental Practice (MP)
Number of subjects: 20
Study: 18310175

Group type: EXPERIMENTAL
Intervention: Best-practice behavioral program
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 134
Study: 16526307

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14586323

Group type: EXPERIMENTAL
Intervention: Emergency cerclage and indomethacin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bed rest only
Number of subjects: 23
Study: 11029565

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (1%, 4%, and 10% concentrations, total doses of 0.5, 2.0, and 5.0 mg kg‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (1%, 4%, and 10% concentrations)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (4% and 10% concentrations)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (4% solution)
Number of subjects: 15
Study: 8803857

Group type: EXPERIMENTAL
Intervention: High self-efficacy condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low self-efficacy condition
Number of subjects: 40
Study: 1999002

Group type: EXPERIMENTAL
Intervention: 250-mg flutamide tablets three times daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: 400-mg sustained-release flutamide tablets twice daily
Number of subjects: 8
Study: 6422790

Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.3 mg i.v.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pentazocine (30 mg i.v.)
Number of subjects: 60
Study: 31109812

Group type: EXPERIMENTAL
Intervention: Pharmacists' knowledge of naloxone formulations
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Pharmacists' ability to counsel on opioid overdose response
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Pharmacists' knowledge of rescue breathing and recovery position
Number of subjects: 79
Study: 30239376

Group type: EXPERIMENTAL
Intervention: Multiple arterial grafts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single arterial grafts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radial artery as a second graft
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saphenous vein as a second graft
Number of subjects: 0
Study: 27181775

Group type: EXPERIMENTAL
Intervention: 20 mg atorvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24123153

Group type: EXPERIMENTAL
Intervention: Free-breathing cardiac MR perfusion sequence with slice tracking
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional perfusion sequence (without slice tracking)
Number of subjects: 20
Study: 22648720

Group type: EXPERIMENTAL
Intervention: Commercially available pureed meats
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Iron-and-zinc-fortified infant cereal (IZFC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Whole-grain, iron-only-fortified infant cereal (IFC)
Number of subjects: 45
Study: 19113918

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 100
Study: 17895235

Group type: EXPERIMENTAL
Intervention: 2% w/v lidocaine with hyaluronidase 15 IU ml(‐1)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 2% w/v lidocaine
Number of subjects: 62
Study: 15167308

Group type: EXPERIMENTAL
Intervention: Soy protein with 96 mg isoflavones/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Soy with 52 mg isoflavones/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Soy without isoflavones (< 4 mg isoflavones/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study: 12501904

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antihypertensive agents in white-coat hypertension
Number of subjects: 0
Study: 9679792

Group type: EXPERIMENTAL
Intervention: Minidose warfarin (1.25 mg/d)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Warfarin plus aspirin (1.25 mg/d + 300 mg/d)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg/d)
Number of subjects: 677

Group type: COMPARATOR
Intervention: Adjusted-dose warfarin (INR 2.0-3.0)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 677
Study: 10068745

Group type: EXPERIMENTAL
Intervention: bismuth‐metronidazole‐tetracycline‐ranitidine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: bismuth‐metronidazole‐amoxicillin‐ranitidine
Number of subjects: 118

Group type: COMPARATOR
Intervention: NSAID's use
Number of subjects: 118

Group type: COMPARATOR
Intervention: Persistent peptic ulcer
Number of subjects: 118
Study: 2652906

Group type: COMPARATOR
Intervention: Nisoldipine (calcium-channel blocker)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Heather-index (impedance cardiography)
Number of subjects: 18
Study: 319713

Group type: EXPERIMENTAL
Intervention: Oral atropine sulfate 0.5 mg four times a day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29415592

Group type: EXPERIMENTAL
Intervention: Interrupted technique of suturing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous technique of suturing
Number of subjects: 0
Study: 29041942

Group type: EXPERIMENTAL
Intervention: ALO-02
Number of subjects: 410
Study: 25416496

Group type: EXPERIMENTAL
Intervention: Nepeta menthoides capsules (400 mg) and conventional drugs
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cuscuta planiflora capsules (500 mg) and conventional drugs
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional drugs only
Number of subjects: 43
Study: 23775051

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 106

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 106
Study: 21782375

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 78

Group type: COMPARATOR
Intervention: Irradiated allograft
Number of subjects: 78
Study: 20516268

Group type: EXPERIMENTAL
Intervention: 800 IU vitamin D(3) daily for 6 months
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 2000 mg elemental calcium daily for 6 months
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both vitamin D(3) and calcium
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 16393311

Group type: EXPERIMENTAL
Intervention: Budesonide foam (2 mg/25 mL)
Number of subjects: 541

Group type: COMPARATOR
Intervention: Budesonide enema (2 mg/100 mL)
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Budesonide foam
Number of subjects: 541

Group type: COMPARATOR
Intervention: Budesonide enema
Number of subjects: 541
Study: 15279915

Group type: EXPERIMENTAL
Intervention: Interactive video intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: High-quality informational intervention (book form)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Commercially available brochures
Number of subjects: 300
Study: 11524314

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia and analgesia (TEA) for 96 hours
Number of subjects: 420

Group type: COMPARATOR
Intervention: General anesthesia (GA) with narcotic analgesia for 72 hours
Number of subjects: 420
Study: 9348757

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activity program including strength training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychoactive drugs (e.g., benzodiazepines)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trophic factors
Number of subjects: 0
Study: 8281985

Group type: EXPERIMENTAL
Intervention: 500 mg acetylsalicylic acid (ASA) infused intravenously
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ASA infusion
Number of subjects: 36
Study: 2947334

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 100
Study: 29540280

Group type: EXPERIMENTAL
Intervention: Caregiver perspectives on asthma management
Number of subjects: 15
Study: 27135598

Group type: EXPERIMENTAL
Intervention: Donor milk
Number of subjects: 373

Group type: COMPARATOR
Intervention: Formula
Number of subjects: 373
Study: 24665827

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 157

Group type: COMPARATOR
Intervention: PF4/H antibody-positive patients
Number of subjects: 157

Group type: COMPARATOR
Intervention: PF4/H antibody-positive patients who survived thrombosis
Number of subjects: 157
Study: 22311204

Group type: EXPERIMENTAL
Intervention: Active rTMS treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list (WTL) group
Number of subjects: 0
Study: 21088095

Group type: EXPERIMENTAL
Intervention: Nebivolol (starting dose 5 mg/day, uptitrated to 10, 20, or 40 mg/day as needed)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 277
Study: 18356758

Group type: EXPERIMENTAL
Intervention: Family-based cognitive-behavioral therapy (CBT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Family-based relaxation treatment (RT)
Number of subjects: 42
Study: 16008322

Group type: EXPERIMENTAL
Intervention: Prostina (2 capsules twice daily for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Terazosin (2 mg at bedtime for 12 weeks)
Number of subjects: 40
Study: 12466730

Group type: EXPERIMENTAL
Intervention: Hydralazine bolus injection (n = 44)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Hydralazine continuous drip in normal saline (n = 33)
Number of subjects: 77